Financials

News Ideas Minds Technicals

8279 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to SYNGEN BIOTECH CO LTD operating, investing, and financing activities

8279 free cash flow for Q1 24 is 29.98 M TWD. For 2023, 8279 free cash flow was 369.55 M TWD and operating cash flow was 461.45 M TWD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—